Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9

被引：33

作者：

Ashok, Bhaargavi ^{[1
]}

Peppas, Nicholas A. ^{[1
,2
,3
,4
,5
]}

Wechsler, Marissa E. ^{[6
]}

机构：

[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA

[2] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA

[3] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA

[4] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA

[5] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA

[6] Univ Texas San Antonio, Dept Biomed Engn & Chem Engn, San Antonio, TX 78249 USA

来源：

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2021年 / 65卷

基金：

美国国家卫生研究院;

关键词：

Hydrogels; Nanoparticles; CRISPR; Genome editing; IN-VIVO; TARGETED DELIVERY; MESSENGER-RNA; T-CELLS; GENE; CARRIERS; CANCER; VITRO; DNA; CRISPR-CAS9;

D O I：

10.1016/j.jddst.2021.102728

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) genome editing systems and their applications in human health and medicine has heralded a new era of biotechnology. However, the delivery of CRISPR therapeutics is arguably the most difficult barrier to overcome for translation to in vivo clinical administration. Appropriate delivery methods are required to efficiently and selectively transport all gene editing components to specific target cells and tissues of interest, while minimizing off-target effects. To overcome this challenge, we discuss and critique nanoparticle delivery strategies, focusing on the use of lipid-based and polymeric-based matrices herein.

引用

页数：13

共 50 条

[1] Lipid-, Inorganic-, Polymer-, and DNA-Based Nanocarriers for Delivery of the CRISPR/Cas9 system
Song, Nachuan
Chu, Yiwen
Tang, Jianpu
Yang, Dayong
CHEMBIOCHEM, 2023, 24 (16)
[2] Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
Kazemian, Pardis
Yu, Si-Yue
Thomson, Sarah B.
Birkenshaw, Alexandra
Leavitt, Blair R.
Ross, Colin J. D.
MOLECULAR PHARMACEUTICS, 2022, 19 (06) : 1669 - 1686
[3] Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Duan, Li
Ouyang, Kan
Xu, Xiao
Xu, Limei
Wen, Caining
Zhou, Xiaoying
Qin, Zhuan
Xu, Zhiyi
Sun, Wei
Liang, Yujie
FRONTIERS IN GENETICS, 2021, 12
[4] Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
Lingmin Zhang
Peng Wang
Qiang Feng
Nuoxin Wang
Zitian Chen
Yanyi Huang
Wenfu Zheng
Xingyu Jiang
NPG Asia Materials, 2017, 9 : e441 - e441
[5] Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
Zhang, Lingmin
Wang, Peng
Feng, Qiang
Wang, Nuoxin
Chen, Zitian
Huang, Yanyi
Zheng, Wenfu
Jiang, Xingyu
NPG ASIA MATERIALS, 2017, 9 : e441 - e441
[6] Lipid- and Polymer-Based Nanostructures for Cutaneous Delivery of Curcumin
Thiago Caon
Letícia Mazzarino
Cláudia Maria Oliveira Simões
Elenara Lemos Senna
Marcos Antônio Segatto Silva
AAPS PharmSciTech, 2017, 18 : 920 - 925
[7] Lipid- and Polymer-Based Nanostructures for Cutaneous Delivery of Curcumin
Caon, Thiago
Mazzarino, Leticia
Oliveira Simoes, Claudia Maria
Senna, Elenara Lemos
Segatto Silva, Marcos Antonio
AAPS PHARMSCITECH, 2017, 18 (03): : 920 - 925
[8] Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics
Chen, Fengqian
Alphonse, Martin
Liu, Qi
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2020, 12 (03)
[9] Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
Caprifico, Anna E.
Foot, Peter J. S.
Polycarpou, Elena
Calabrese, Gianpiero
PHARMACEUTICS, 2022, 14 (09)
[10] Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system
Madhi, Zaid Saad
Shallan, Mohammed Ali
Almaamuri, Abdulhusein Mizhir
Alhussainy, Ammar Abbas
AL-Salih, Sadiq Salam S.
Raheem, Abdulla K.
Alwan, Hameed Jassem
Jalil, Abduladheem Turki
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 78

← 1 2 3 4 5 →